Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors

Research output: Contribution to journalJournal articleResearchpeer-review

  • Zohreh Ketabi
  • Katarina Bartuma
  • Inge Bernstein
  • Susanne Malander
  • Henrik Grönberg
  • Erik Björck
  • Susanne Holck
  • Nilbert, Mef Christina
  • Zohreh Ketabi
  • Zohreh Ketabi
OBJECTIVE: Heredity is a major cause of ovarian cancer and during recent years the contribution from germline mismatch repair (MMR) gene mutations linked to Lynch syndrome has gradually been recognized. METHODS: We characterized clinical features, tumor morphology and mismatch repair defects in all ovarian cancers identified in Swedish and Danish Lynch syndrome families. RESULTS: In total, 63 epithelial ovarian cancers developed at mean 48 (range 30-79) years of age with 47% being early stage (FIGO stage I). Histologically, endometrioid (35%) and clear cell (17%) tumors were overrepresented. The underlying MMR gene mutations in these families affected MSH2 in 49%, MSH6 in 33% and MLH1 in 17%. Immunohistochemical loss of the corresponding MMR protein was demonstrated in 33/36 (92%) tumors analyzed. CONCLUSION: The combined data from our cohorts demonstrate that ovarian cancer associated with Lynch syndrome typically presents at young age as early-stage, non-serous tumors, which implicates that a family history of colorectal and endometrial cancer should be specifically considered in such cases.
Original languageEnglish
JournalGynecologic Oncology
Volume121
Issue number3
ISSN0090-8258
DOIs
Publication statusPublished - Jun 2011

ID: 34071102